Skip to content
You are now leaving https://www.ionispharma.com to visit

Miller, T.M. et al.

(2013) An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study. Lancet Neurol. 12(5):435-42.